Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.05
-0.28 (-4.42%)
At close: Jun 5, 2025, 4:00 PM
6.01
-0.04 (-0.66%)
After-hours: Jun 5, 2025, 4:18 PM EDT

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $329.20 million as of June 5, 2025. Its market cap has increased by 13.20% in one year.

Market Cap
329.20M
Enterprise Value
857.95M
1-Year Change
13.20%
Ranking
Category
Stock Price
$6.05

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $329.20M, an increase of 2.62%. That is a compound annual growth rate of 0.14%.

History

DateMarket Cap% Change
Jun 4, 2025343.60M-33.67%
Dec 31, 2024518.00M316.06%
Dec 29, 2023124.50M-78.87%
Dec 30, 2022589.20M-74.81%
Dec 31, 20212.34B-50.75%
Dec 31, 20204.75B70.50%
Dec 31, 20192.79B-7.78%
Dec 31, 20183.02B57.00%
Dec 29, 20171.92B44.63%
Dec 30, 20161.33B-14.64%
Dec 31, 20151.56B52.38%
Dec 31, 20141.02B22.29%
Dec 31, 2013836.10M45.38%
Dec 31, 2012575.10M-5.00%
Dec 30, 2011605.40M-25.67%
Dec 31, 2010814.50M94.58%
Dec 31, 2009418.60M-46.42%
Dec 31, 2008781.20M419.07%
Dec 31, 2007150.50M-50.82%
Dec 29, 2006306.00M-4.61%
View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 690.37B
Johnson & Johnson 370.13B
AbbVie 333.89B
Novo Nordisk 315.80B
UnitedHealth Group 273.29B
Abbott Laboratories 232.62B
Novartis AG 226.74B
AstraZeneca 223.00B
Market Cap Rankings